medicament 3004490040

💊 Medicament (Medicines) – HS Code 3004.49.00.40 Analysis

🌐 HS Code Reference & Customs Clearance Guide | 2026 Latest Tariff Analysis | Professional Compliance Strategy
📌 I. Product Definition: What is a "Medicament"?

Medicaments are substances or combinations of substances used in diagnosing, treating, or preventing diseases in humans or animals. In international trade, they fall under Chapter 30 (Pharmaceutical Products).

The specific HS Code 3004.49.00.40 indicates: - Category: Medicaments consisting of mixed or unmixed products. - Sub-category: Not containing penicillin or derivatives thereof, nor streptomycin or derivatives thereof (which would fall under different sub-headings like 3004.20 or 3004.30). - Form: Prepared in measured doses (e.g., tablets, capsules, sachets) or put up for retail sale.

⚠️ Key Distinction:
- If the medicament contains Penicillin/Streptomycin → It does NOT belong here.
- If it is a vaccine → It belongs in Heading 30.02.
- If it is a pure substance not in measured doses → It may belong in Heading 30.03.
- 3004.49.00.40 is typically a "catch-all" or specific national sub-category for other mixed/unmixed medicaments not elsewhere specified.

📦 II. HS Code Classification Detail (Based on Provided Data)

According to the provided <DATA>, the HS Code 3004.49.00.40 is explicitly linked to the product name "Medicament".

🔍 Detailed Explanation from Data:
- "The product name directly corresponds to drug usage, with no material or form conflict."
- This confirms that the item is a finished pharmaceutical product, not an active ingredient in bulk (which would be 30.03) or a simple herbal extract without medicinal claims (which might be 12.11 or 13.02).

💰 III. 2026 Latest Tariff Rate Breakdown

✅ Applicable Country: United States (US)
✅ Origin: China (CN) (Implied by the presence of Section 301 and IEEPA tariffs in the data)
✅ Effective Date: 2025/2026 Period

🎯 HS Code: 3004.49.00.40

📌 Interpretation:
- Base Duty (0%): The US generally applies low or zero duties on essential medicines to ensure access.
- Section 122 Tariff (10%): This appears to be a specific retaliatory or targeted tariff applied to this category from China. Note: Section 122 is often invoked under the International Emergency Economic Powers Act (IEEPA) or other trade remedy tools.
- No Section 301 Surcharge: Unlike electronics or steel, pharmaceuticals often enjoy exemptions from the broad Section 301 tariffs.
- Total Cost Impact: Importers must budget for a 10% additional duty on top of the CIF value.

🛠️ IV. Customs Clearance Practical Advice

✅ 1. Required Documentation Checklist

✅ 2. Critical Compliance Tips

🔥 “Pharma is not general cargo! Regulatory clearance precedes customs clearance.”

📌 Important Note on De Minimis:
The $800 de minimis exemption (Section 321) DOES NOT apply to pharmaceutical products. Every shipment, regardless of value, requires full FDA and CBP documentation. Do not use Amazon-style direct shipping without proper FDA registration.

✅ 3. Special Considerations for HS 3004.49.00.40

1. Exact Composition Matters:

   • If the medicament contains antibiotics other than penicillin/streptomycin (e.g., tetracycline), it still falls under 3004.49, but ensure the COA matches.
   • If it contains vitamins/minerals marketed as medicines, it may still be classified under 3004, not 21.06.

2. Section 122 Tariff Strategy:

   • Since the total tariff is 10%, check if the product qualifies for any GSP (Generalized System of Preferences) benefits if shipped from eligible countries (though China is generally not eligible for GSP).
   • Investigate if exclusions exist under the specific Section 122 authority for certain therapeutic classes.

3. FDA Alignment:

   • CBP (Customs) will often hold the shipment until FDA releases it. Ensure all electronic submissions (ACE/ABI) are complete.
   • Misclassification can lead to FDA Refusal to Admit, resulting in destruction or re-export at your cost.

🌍 V. Global Market Comparison (2026)

📌 Conclusion:
- The USA imposes a 10% tariff on this category, likely due to trade policies.
- Regulatory barriers (FDA) are the primary hurdle, not just tariffs.
- Compared to the EU (0%), the US cost structure is higher.

📌 VI. Common Mistakes & Pitfalls (Lessons Learned)

❌ Mistake 1: Ignoring FDA Prior Notice
👉 Consequence: Cargo held at port for weeks, then destroyed. Cost: 100% of goods + storage fees.

❌ Mistake 2: Misclassifying Active Ingredients as "Medicaments"
👉 Consequence: HS Code 30.03 vs 30.04 differences. If bulk powder is declared as tablets, penalty + seizure.

❌ Mistake 3: Assuming De Minimis Applies
👉 Consequence: Attempting to ship small quantities under $800 without FDA entry. Automatic rejection.

❌ Mistake 4: Overlooking Section 122 Tariff
👉 Consequence: Underpaying duties by 10%. Audit trail leads to back-taxes + interest.

✅ Correct Approach:

"Medicament, Tablet Form, 500mg, Pack of 100, Contains [Active Ingredient], NDA Number: XXXXX, Origin: China, HS Code: 3004.49.00.40"

🎯 VII. Conclusion: Professional Clearance, Risk Mitigation

🎯 Key Takeaways:

🔹 HS Code 3004.49.00.40 is correct for general medicaments not containing penicillin/streptomycin.
🔹 Total Tariff is 10% (Section 122).
🔹 FDA Compliance is non-negotiable. No prior notice = No entry.
🔹 De Minimis Exemption Does Not Apply.

📌 Pro Tip:
If you are importing from China, consult a US FDA-registered agent to handle Prior Notice and ensure the facility is listed in the FDA database.
Consider applying for CBP Pre-Clearance or C-TPAT certification to speed up inspection.

📣 Action Required:

📞 Engage a licensed customs broker with pharma expertise.
📋 Prepare FDA Prior Notice at least 2-5 days before arrival.
🚀 Ensure accurate HS Code declaration to avoid 10% underpayment penalties.

✨ Precision in Pharma Classification Saves Time, Money, and Lives!
💼 Your Compliance is Your Competitive Advantage!